Live News EQUITY FLASH L impact Oct 26, 2026, 09:27 AM UTC Bayer Wins China Approval for Asundexian, First FXIa Inhibitor Bayer received marketing authorization from China's NMPA for Sunharbro (asundexian) 50 mg. BAYRY SquawkNews Desk